Back
MoonLake Immunotherapeutics Stock Predictions

One Tool. Personalized Setups.
Try it here.
Buy
66
MLTX
MoonLake Immunotherapeutics
Last Price:
$48.95
Seasonality Move:
19.44%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report NowMoonLake Immunotherapeutics Stock Forecast
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 204.8% based on the past 4 years of stock performance.
-
MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is MoonLake Immunotherapeutics Stock Undervalued?The current MoonLake Immunotherapeutics [MLTX] share price is $48.89. The Score for MLTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
MLTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 204.8% based on the past 4 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Buy
66
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics overpriced?
-
MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
58.26
52-Week Low:
31.42
Prediction Charts
Market Cap:
3.1B
Price in USD:
48.89
Volume:
244.1K
Beta:
1.28
Technical Analysis
SMA50:
42.39
SMA100:
41.03
SMA200:
45.60
52-Wk Change:
15.85%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?Yes, MoonLake Immunotherapeutics is a publicly traded company.
-
What is the MoonLake Immunotherapeutics stock quote today?The MoonLake Immunotherapeutics stock price is 48.89 USD today.
-
How to buy MoonLake Immunotherapeutics stock online?You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-13 | 43.36 | 44.21 | 44.43 | 42.97 |
Jun-16 | 44.85 | 42.90 | 44.94 | 42.85 |
Jun-17 | 42.39 | 43.00 | 43.29 | 42.22 |
Jun-18 | 43.33 | 43.50 | 44.20 | 42.93 |
Jun-20 | 44.00 | 43.50 | 44.00 | 43.04 |
Jun-23 | 43.41 | 44.87 | 44.91 | 43.04 |
Jun-24 | 45.23 | 45.76 | 46.18 | 44.67 |
Jun-25 | 46.00 | 47.37 | 47.43 | 45.49 |
Jun-26 | 47.69 | 47.29 | 47.69 | 46.39 |
Jun-27 | 47.38 | 47.52 | 48.72 | 46.90 |
Jun-30 | 47.82 | 47.20 | 48.49 | 46.99 |
Jul-1 | 47.08 | 46.61 | 47.93 | 46.24 |
Jul-2 | 46.67 | 47.86 | 48.02 | 46.32 |
Jul-3 | 48.12 | 48.89 | 49.29 | 47.87 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.20 per share, and a decrease next year of $0.62 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.